New MRI Agent Detects Lung Cancer
ATLANTA – Georgia State University researchers have developed a new protein-based MRI contrast agent that may help detect aggressive lung cancer and metastatic disease much earlier than conventional imaging. The technology, called hProCA32.Collagen, targets collagen type I, which is often elevated in invasive tumors, and was able to identify tumors and metastases as small as 1 millimeter in preclinical studies. The method was also able to reveal cancer spread to organs including the adrenal glands…